SHARE...
Surgery – Biopsies Cause Metastasis – New Study finds
Questioning Chemotherapy – Dr. Ralph Moss
New Findings Support Warburg Theory Of Cancer
Kickbacks for Drugs Are Dangerous
Influence of Big Pharma on social media
Dr. Michelakis May 2012 paper published in Oncogene
Common Chemotherapy Drugs and Side Effects
Chemotherapy Does Not Work – Dr. Ralph Moss
Cancer Research – A Super Fraud?
By Jon Barron, “Chemotherapy: An Interesting Option”
British Journal of Cancer DCA Mini Review
Breast Cancer Awareness Month Misleads Women
1 in 3 patients harmed during hospital stay
Observe that a number of DCA derivatives are being studied as potential treatments. Why not just use NaDCA? Once again, money takes precedence over human misery, and attempts to find a solution are suppressed because only continued medical care brings in money.
Dichloroacetate
+ Author Affiliations
Abstract
A possibly new family of oral diabetes medications called dichloroacetate (DCA) lowers blood sugar and cholesterol levels without increasing insulin secretion. By preventing hepatic glucose production and promoting glucose clearance and use by peripheral tissues, DCA lowers blood sugar levels. Pyruvate dehydrogenase (PDH), the rate-limiting enzyme of aerobic glucose oxidation, is one of the drug’s main sites of action. When PDH is stimulated by DCA, peripheral alanine and lactate oxidation increases, interrupting the Cori and alanine cycles and decreasing the amount of three-carbon precursors for gluconeogenesis that are available. In experimental models of ketosis, DCA drastically lowers blood glucose while reducing both ketonemia and ketonuria.
Hepatic triglyceride and cholesterol production is suppressed by DCA. Short-term tests on people with non-insulin-dependent diabetes have shown that the medication has the ability to significantly lower levels of circulating very-low-density lipoprotein cholesterol and triglycerides. Oral treatment of DCA dramatically lowers insulin needs and blood levels of glucose and lipids in hereditary models of insulin-dependent diabetes.
It has been discovered that some DCA derivatives exhibit biological activity in animals after being produced. If DCA and its equivalents are safe and useful medications for long-term management of the lipid and carbohydrate imbalances in human diabetes, more research is needed to confirm this.
Copyright © 1992 by the American Diabetes Association
Link to article
http://care.diabetesjournals.org/content/15/6/785
DCA Effects f Glucose and Fat Metabolism in normal and diabetic tissue
http://www.sciencedirect.com/science/article/pii/0026049570901198
MEDICAL PUBLICATIONS
The Efficacy of Chemotherapy for Cancer
PDF Clinical Trial Publication U of A 2010
F.D.A. Approves Drug for Bone Marrow Disease
Absence of Mutagenic Effects of Sodium Dichloroacetate
Informational Guide:
DCA guide
© 2022 DCA WATCH
RECENT COMMENTS